Interferon-induced Parkinsonism in a patient with chronic hepatitis C.
Almeida
Carlos Mauricio Oliveira de
CM
Neurology Department, Fundação de Medicina Tropical do Amazonas, Brazil. acrmauri@ig.com.br
Galvão
Maria de Lourdes de Souza
Mde L
Ferreira
Paulo Luis da Costa
PL
Braga
Wornei Silva
WS
D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a